Clinical Trials Logo

Filter by:
NCT ID: NCT04831060 Recruiting - Periodontitis Clinical Trials

Periodontitis and Inflammation

CB-PARO
Start date: February 15, 2023
Phase:
Study type: Observational

Today, to understand pathogenic mechanisms involved in periodontitis remains a challenge to identify biomarkers or therapeutic targets to improve prevention and screening, as well as the effectiveness of periodontitis treatments. The aim is to characterize, in vivo, specific molecular markers reflecting the activity of the pathology, which could lead to - improve the knowledge of the pathogenesis of periodontitis; - determine target molecules involved in tissue destruction; - determine molecular profiles of patients at local and systemic risk; - determine therapeutic targets For this purpose, biological samples will be collected (plaque, saliva, crevicular fluid) from patients with periodontitis stage 3 or 4 versus patients with a healthy periodontium. Biological samples will be collected before and all along the periodontal treatment. Gingiva explants collection will be sampling within the surgical procedures (if they are needed). The primary objective is to investigate tissue and cellular expression of molecular markers associated with periodontal destruction during periodontitis in relation to periodontal infection and systemic changes in host response. A characterization of the cytokines in gingival fluid and unstimulated saliva (Luminex® technique) of patients with periodontitis versus without periodontitis will be done. The secondary objective is to study the influence of periodontitis on systemic pathologies via serum analysis of molecules and bacteria involved in periodontal destruction. Immunofluorescence evaluation of protein expression and distribution (inflammatory mediators, inflammatory pathway signaling proteins) in gingival explants, characterization of proteases (MMP) present in gingival fluid and unstimulated saliva (Luminex® technique) and microbiological analysis of the subgingival biofilm (by quantitative PCR).

NCT ID: NCT04831021 Recruiting - Clinical trials for Chronic Kidney Diseases

Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?

EXP DIAL
Start date: September 24, 2021
Phase: N/A
Study type: Interventional

This study aims at evaluating, in chronic kidney disease patients on dialysis, the effect of acute per- or pre-dialytic physical exercise on regional myocardial function and myocardial stunning, blood viscosity, arterial stiffness, variability of sinus rhythm, dialysis efficacy, inflammation, mineral and bone disorders, myokines and cardiac remodeling markers.

NCT ID: NCT04830436 Active, not recruiting - Stroke Clinical Trials

Impact of Undernutrition in Patients Over 70 Years of Age Thrombolysed and/or Thrombectomized for Stroke

Denut_AVC
Start date: March 31, 2021
Phase:
Study type: Observational

Undernutrition is a frequent problem in hospitals (at least 30% of patients, SENECA-NHANES studies). Its impact on morbidity and mortality is well known in gerontology, oncology and intensive care. There are very few neurovascular studies dealing with the consequences of undernutrition present before the stroke. Indeed, most of the medical literature concerns only undernutrition acquired after a stroke. The investigator propose to analyze medical data from a cohort of patients over 70 years of age thrombolysed and/or thrombectomized in the neurovascular department between the years 2014 and 2019.

NCT ID: NCT04830241 Active, not recruiting - Pregnancy Related Clinical Trials

Neonatal Hypotonia Associated With in Utero Exposure to Antidepressant

Start date: March 25, 2021
Phase:
Study type: Observational

To better characterize the neonatal hypotonia associated with in utero exposure to antidepressants, so far limited to clinical cases, we will perform an observational retrospective pharmacovigilance study, using two databases. First, disproportionality analysis in Vigibase®, the World Health Organization global database, will be perform between antidepressant drugs and neonatal hypotonia . Second, narratives from the French National Pharmacovigilance Database will be extracted.

NCT ID: NCT04830228 Active, not recruiting - Clinical trials for Peripheral Artery Disease

BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

BIONETIC-I
Start date: August 10, 2021
Phase:
Study type: Observational

BIOTRONIK cobalt chromium balloon-expandable Dynetic-35 stent in association with Passeo-35 Xeo peripheral dilation catheter for the treatment of peripheral iliac lesions

NCT ID: NCT04830007 Suspended - Pregnancy, Unwanted Clinical Trials

Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy

Start date: November 2022
Phase:
Study type: Observational

The study will be offered to all women who are consultant for an abortion plan are seen in consultation at the orthogeny center where the study will be conducted. Of these 700 women, about 10% will not agree to participate in the study and 10% will not meet the inclusion criteria. Thus it's plane to include 560 patients in the study.

NCT ID: NCT04829994 Recruiting - Clinical trials for Stress Urinary Incontinence

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

Start date: July 8, 2021
Phase:
Study type: Observational

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

NCT ID: NCT04829812 Completed - Clinical trials for Peripheral Arterial Disease

Medical Compression in Patients With Chronic Wound and Peripheral Arterial Disease

COMPAD2
Start date: March 15, 2021
Phase:
Study type: Observational

Real-life practice survey of vascular specialist in France caring for patients with chronic wound for which compression treatment would be indicated and arterial disease of the lower limbs

NCT ID: NCT04829604 Recruiting - Clinical trials for HER2 Positive Metastatic Breast Cancer

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Start date: October 26, 2021
Phase: Phase 2
Study type: Interventional

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd

NCT ID: NCT04829578 Completed - Clinical trials for Chronic Idiopathic Pruritus

Hypnosis for Chronic Idiopathic Pruritus

Start date: April 13, 2021
Phase: N/A
Study type: Interventional

Chronic idiopathic pruritus (CIP) is a frequent and disabling condition, for which there is no specific treatment. It was shown previously that hypnosis can relieve painful sensations. Pain and pruritus share many similarities regarding sensory receptors and pathways, suggesting that hypnosis might help relief CIP.